You are here

  • Home
  • Archive
  • Volume 10, Issue 9
  • Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64)

Article metrics

Article menu

This article has a correction. Please see:

Clinical/translational cancer immunotherapy
Original research
Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64)

 

Online download statistics by month:

Online download statistics by month: September 2022 to July 2025

AbstractFullPdf
Sep 2022424429164
Oct 202218719488
Nov 202216216461
Dec 202210510528
Jan 202314314455
Feb 2023777838
Mar 2023939626
Apr 2023454629
May 2023575718
Jun 2023565616
Jul 2023626224
Aug 2023686829
Sep 2023606023
Oct 2023686819
Nov 2023717215
Dec 2023949523
Jan 2024686929
Feb 2024818337
Mar 2024737346
Apr 2024707033
May 2024575724
Jun 2024606017
Jul 2024989936
Aug 2024474719
Sep 2024686933
Oct 2024838625
Nov 2024969736
Dec 2024585919
Jan 202513113323
Feb 2025798035
Mar 2025959649
Apr 202511311346
May 2025717329
Jun 2025404021
Jul 2025110
Total316131991213